Association between interleukin 21 and Graves’ disease

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3338-3346

  Jia, H Y ^a   Zhang, Z G ^a   Gu, X J ^b   Guo, T ^a   Cui, B ^a   Ning, G ^a   Zhao, Y J ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Graves disease; Graves ophthalmopathy; IL 21

Indexed keywords

INTERLEUKIN 21; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HAPLOTYPE; HUMAN; IL 21 GENE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; BLOOD; CHINA; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HAPLOTYPES; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84865637800     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.October.31.6     Document Type: Article

References (31)

1. Bahn RS (1995). Assessment and management of the patient with Graves' ophthalmopathy. Endocr. Pract. 1: 172-178.
2. Ban Y and Tomer Y (2003). The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379.
3. Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
4. Bednarczuk T, Gopinath B, Ploski R and Wall JR (2007). Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin. Endocrinol. 67: 3-19.
5. Caprioli F, Sarra M, Caruso R, Stolfi C, et al. (2008). Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807.
6. Caruso R, Fina D, Peluso I, Fantini MC, et al. (2007). IL-21 is highly produced in Helicobacter pylori -infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178: 5957-5965.
7. Chen RH, Chen WC, Chang CT, Tsai CH, et al. (2005). Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138.
8. Davis ID, Skak K, Smyth MJ, Kristjansen PE, et al. (2007). Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13: 6926-6932.
9. Farid NR and Balazs C (1998). The genetics of thyroid associated ophthalmopathy. Thyroid 8: 407-409.
10. Hiromatsu Y, Kaku H, Miyake I, Murayama S, et al. (2002). Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12: 217-221.
11. Hiromatsu Y, Mukai T, Kaku H, Miyake I, et al. (2006). IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet. Med. 23: 211-215.
12. Kasaian MT, Whitters MJ, Carter LL, Lowe LD, et al. (2002). IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16: 559-569.
13. Leonard WJ and Spolski R (2005). Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698.
14. Liang J, Chen P, Hu Z, Zhou X, et al. (2008). Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29: 2341-2346.
15. Lin MC, Hsu FM, Bee YS and Ger LP (2008). Age influences the severity of Graves' ophthalmopathy. Kaohsiung J. Med. Sci. 24: 283-288.
16. Liu R, Van KL, La CA, Price M, et al. (2006). Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176: 5247-5254.
17. Liu Y, Helms C, Liao W, Zaba LC, et al. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4: e1000041.
18. Mehta DS, Wurster AL and Grusby MJ (2004). Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95.
19. Meller J, Jauho A, Hufner M, Gratz S, et al. (2000). Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10: 1073-1079.
20. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, et al. (1989). Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73: 639-644.
21. Ozaki K, Spolski R, Feng CG, Qi CF, et al. (2002). A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
22. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, et al. (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
23. Piao WH, Jee YH, Liu RL, Coons SW, et al. (2008). IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 67: 37-46.
24. Solé X, Guinó E, Valls J, Iniesta R, et al. (2006). SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929.
25. Spolski R and Leonard WJ (2008a). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79.
26. Spolski R and Leonard WJ (2008b). The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20: 295-301.
27. Strengell M, Matikainen S, Siren J, Lehtonen A, et al. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464-5469.
28. Vollmer TL, Liu R, Price M, Rhodes S, et al. (2005). Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174: 2696-2701.
29. Wall JR, Salvi M, Bernard NF, Boucher A, et al. (1991). Thyroid-associated ophthalmopathy-a model for the association of organ-specific autoimmune disorders. Immunol. Today 12: 150-153.
30. Weetman AP, Cohen S, Gatter KC, Fells P, et al. (1989). Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin. Exp. Immunol. 75: 222-227.
31. Yamada M, Li AW and Wall JR (2000). Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit. Rev. Clin. Lab. Sci. 37: 523-549.